[1] MOSLEMI F,TAHERI P,AZIMIPOOR M,et al.Effect of angiotensin Ⅱtype 1 receptor blockade on kidney ischemia/reperfusion; a gender-related difference[J].J Renal Inj Prev,2016,5(3):140-143.
[2] LUO L N,XIE Q,ZHANG X G,et al.Osthole decreases renal ischemia-reperfusion injury by suppressing JAK2/STAT3 signaling activation[J].Exp Ther Med,2016,12(4):2009-2014.
[3] XU Y M,DING G H,HUANG J,et al.Tanshinone ⅡA pretreatment attenuates ischemia/reperfusion-induced renal injury[J].Exp Ther Med,2016,12(4):2741-2746. a P<0.05图6各组间细胞凋亡情况A.各组间流式细胞仪检测结果;B.定量分析结果a P<0.05图7 T-Ⅰ缓解H2O2诱导的HK-2内氧化应激水平A.各组细胞内ROS水平;B.其荧光强度定量
[4] CARDEN D L,GRANGER D N.Pathophysiology of ischaemia-reperfusion injury[J].J Pathol,2000,190(3):255.
[5] ZHOU L,ZUO Z,CHOW M S.Danshen:an overview of its chemistry,pharmacology,pharmacokinetics,and clinical use[J].J Clin Pharmacol,2005,45(12):1345-1359.
[6] TIAN X H,WU J H.Tanshinone derivatives:a patent review (January 2006-September 2012)[J].Expert Opin Ther Pat,2013,23(1):19.
[7] de OLIVEIRA M R,SCHUCK P F,BOSCO S M D.Tanshinone Ⅰ induces mitochondrial protection through an Nrf2-dependent mechanism in paraquat-treated human neuroblastoma SH-SY5Y cells[J].Mol Neurobiol,2017,54(6):4597-4608.
[8] TAO S,ZHENG Y,LAU A,et al.Tanshinone Ⅰ activates the Nrf2-dependent antioxidant response and protects against As(Ⅲ)-induced lung inflammation in vitro and in vivo[J].Antioxid Redox Signal,2013,19(14):1647-1661.
[9] JING X,WEI X,REN M,et al.Neuroprotective effects of Tanshinone Ⅰ against 6-OHDA-induced oxidative stress in cellular and mouse model of Parkinson's disease through upregulating Nrf2[J].Neurochem Res,2016,41(4):779-786.
[10] CHEN Y T,YANG C C,ZHEN Y Y,et al.Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury[J].Stem Cell Res Ther,2013,4(3):62.
[11] DONNAHOO K K,MELDRUM D R,SHENKAR R,et al.Early renal ischemia,with or without reperfusion,activates NFkappaB and increases TNF-alpha bioactivity in the kidney[J].J Urol,2000,163(4):1328-1332.
[12] STALLONE G,INFANTE B,GESUALDO L.Older donors and older recipients in kidney transplantation[J].J Nephrol,2010,23(Suppl 15):S98-103.
[13] KOSIERADZKI M,ROWINSKI W.Ischemia/reperfusion injury in kidney transplantation:mechanisms and prevention[J].Transplant Proc,2008,40(10):3279-3288.
[14] PERICO N,CATTANEO D,SAYEGH M H,et al.Delayed graft function in kidney transplantation[J].Lancet,2004,364(9447):1814-1827.
[15] DEVARAJAN P.Update on mechanisms of ischemic acute kidney injury[J].J Am Soc Nephrol,2006,17(6):1503-1520.
[16] QIU X F,FU K,ZHAO X Z,et al.Protective effects of astaxanthin against ischemia/reperfusion induced renal injury in mice[J].J Transl Med,2015,13:28.
[17] GUNAL O,AKTAN A O,YEGEN C,et al.Captopril prevents the oxidative damage to proteins after renal ischemia reperfusion injury:role of endothelin-1[J].Prostag Leukotr Ess,1997,56(1):23-27.
[18] ESREFOGLU M,TOK O E,AYDIN M S,et al.Effects of beta-glucan on protection of young and aged rats from renal ischemia and reperfusion injury[J].Bratisl Lek Listy,2016,117(9):530-538.
[19] LEE J C,PARK J H,PARK O K,et al.Neuroprotective effects of Tanshinone Ⅰ from Danshen extract in a mouse model of hypoxia-ischemia[J].Anat Cell Biol,2013,46(3):183.
[20] TAO S,JUSTINIANO R,ZHANG D D,et al.The Nrf2-inducers Tanshinone Ⅰ and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV[J].Redox Biol,2013,1:532-541. |